Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy

Johan Jendle; Marcia A. Testa; Sherry Martin; Honghua Jiang; Zvonko Milicevic

doi:10.1111/dom.12705

Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy

Diabetes Obesity and Metabolism ◽

10.1111/dom.12705 ◽

2016 ◽

Vol 18 (10) ◽

pp. 999-1005 ◽

Cited By ~ 17

Author(s):

Johan Jendle ◽

Marcia A. Testa ◽

Sherry Martin ◽

Honghua Jiang ◽

Zvonko Milicevic

Keyword(s):

Type 2 Diabetes ◽

Continuous Glucose Monitoring ◽

Insulin Lispro ◽

Receptor Agonist ◽

Glucose Monitoring ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

Diabetes Care ◽

10.2337/dc19-2316 ◽

2020 ◽

Vol 43 (10) ◽

pp. 2509-2518 ◽

Cited By ~ 2

Author(s):

Julio Rosenstock ◽

Antonio Nino ◽

Joseph Soffer ◽

Lois Erskine ◽

Andre Acusta ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Therapy ◽

Randomized Trial ◽

Receptor Agonist ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulin Use

Download Full-text

Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus: Results over 52 weeks

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2017.05.010 ◽

2017 ◽

Vol 31 (8) ◽

pp. 1283-1285 ◽

Cited By ~ 6

Author(s):

Lawrence A. Leiter ◽

Jorge Luiz Gross ◽

Francis Chow ◽

Diane Miller ◽

Susan Johnson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Receptor Agonist ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Faculty Opinions recommendation of Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738371721.793577217 ◽

2020 ◽

Author(s):

John Tayek

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Therapy ◽

Randomized Trial ◽

Receptor Agonist ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulin Use

Download Full-text

Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) Patients

Diabetes ◽

10.2337/db18-2231-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2231-PUB

Author(s):

SASAN FAZELI ◽

NICOLE EHRHARDT

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Receptor Agonist ◽

Premixed Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes

Diabetes ◽

10.2337/db20-938-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 938-P

Author(s):

RALEIGH E. MALIK ◽

REEMA MODY ◽

MAUREEN J. LAGE ◽

KRISTINA BOYE

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Timing Of Initiation ◽

The Relationship

Download Full-text

Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies

Diabetes Therapy ◽

10.1007/s13300-021-01021-1 ◽

2021 ◽

Author(s):

Thomas M. Caparrotta ◽

Jack B. Templeton ◽

Thomas A. Clay ◽

Sarah H. Wild ◽

Rebecca M. Reynolds ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Observational Studies ◽

Receptor Agonist ◽

Population Based ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

Clinical Diabetes ◽

10.2337/cd17-0065 ◽

2018 ◽

Vol 36 (2) ◽

pp. 138-147 ◽

Cited By ~ 4

Author(s):

Vanita R. Aroda ◽

Joseph R. Arulandu ◽

Anthony J. Cannon

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Receptor Agonist ◽

Two Agents ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Better Than

Download Full-text

4324Effects of the glucagon like peptide-1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment

European Heart Journal ◽

10.1093/eurheartj/ehy563.4324 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

I Ikonomidis ◽

G Pavlidis ◽

V Lambadiari ◽

F Kousathana ◽

H Triantafyllidi ◽

...

Keyword(s):

Oxidative Stress ◽

Type 2 Diabetes ◽

Arterial Stiffness ◽

Receptor Agonist ◽

Myocardial Deformation ◽

Newly Diagnosed ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

And Oxidative Stress

Download Full-text

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients

Diabetes Obesity and Metabolism ◽

10.1111/dom.12089 ◽

2013 ◽

Vol 15 (8) ◽

pp. 770-773 ◽

Cited By ~ 23

Author(s):

N. D. Hopkins ◽

D. J. Cuthbertson ◽

G. J. Kemp ◽

C. Pugh ◽

D. J. Green ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Endothelial Function ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text